Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01642225 · ClinicalTrials.gov registry record
Desensitization Protocol for Deceased Donor List
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 180
- Enrollment target
NCT01642225: Completed study, sponsored by University of Miami.
NCT01642225 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 180 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01642225 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 180 participants
- Enrollment target
Study Summary
Purpose of the study: The specific aims of this study are to evaluate overall efficacy and safety of the pre-transplant IVIG treatment in our transplant center since 2007 and to identify factors affecting treatment outcomes in order to improve patient selection and treatment protocols for future patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-06 |
What the finished NCT01642225 record still lists
NCT01642225 is an observational study that tracks outcomes without assigning an intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01642225 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01642225 about?
NCT01642225 is a clinical study titled "Desensitization Protocol for Deceased Donor List". Purpose of the study: The specific aims of this study are to evaluate overall efficacy and safety of the pre-transplant IVIG treatment in our transplant center since 2007 and to identify factors affecting treatment outcomes in order to improve patient selection and treatment protocols for future pa...
What is the current status of trial NCT01642225?
This trial is currently completed. The enrollment target is 180 participants. The study started on 2012-06. Estimated completion is 2014-06.
Who is sponsoring clinical trial NCT01642225?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia